Earnings Report Digest

Abbott Laboratories (ABT), 2025 Q2 earnings digest

1 min ¡ 18. juli 2025
episode Abbott Laboratories (ABT), 2025 Q2 earnings digest cover

Beskrivelse

$ABT has released its Q2 2025 earnings, where EPS of $1.26 met expectations while revenue reached $11.14B, reflecting a 7.37% year-over-year increase. Despite a 1.5% decline in diagnostics sales, particularly in COVID testing, other divisions showed resilience with medical devices growing by 12%. Key risks include ongoing headwinds from COVID impacts and geopolitical issues in China. Future opportunities hinge on product advancements, especially in diabetes care and biosimilars. 📊✨ For more details, check valueverge.com/ABT.

Kommentarer

0

VÌr den første til ü kommentere

Registrer deg nĂĽ og bli medlem av Earnings Report Digest sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Müned etter prøveperioden. ¡ Avslutt nür som helst.

  • Eksklusive podkaster
  • 20 timer lydbøker i mĂĽneden
  • Gratis podkaster

Alle episoder

469 Episoder